文献速递主动脉疾病

家族性腹主动脉瘤修复术在血管质量倡议中的结局

Outcomes of familial abdominal aortic aneurysm repair in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2018-07-29

本研究基于血管质量倡议2003至2017年数据,回顾性比较1997例家族性腹主动脉瘤(fAAA)与18185例散发性腹主动脉瘤(spAAA)患者接受开放修复(OAR)和腔内修复(EVAR)的结局。结果显示fAAA患者术后并发症和死亡率并未增加,作者认为EVAR和OAR对fAAA患者均安全有效,但需更长期随访研究。

要点

  • fAAA患者较spAAA患者更年轻,更常接受OAR,且髂动脉瘤样变更多见。
  • OAR后fAAA患者复合早期并发症减少,拔管更早、输血更少、住院更短。
  • EVAR后fAAA与spAAA的30天死亡率和长期死亡率无显著差异。

核心结论

  • 家族性腹主动脉瘤患者接受修复术后发病率和死亡率未增加。
  • 作者认为EVAR和OAR对fAAA患者均安全有效。
  • 需要更长期随访的进一步研究以最佳照护这一独特队列。

研究设计与样本

  • 回顾性综述,纳入血管质量倡议2003至2017年所有腹主动脉瘤修复病例。
  • 排除已知遗传综合征患者及长期随访率低于50%的中心。
  • fAAA患者1997例,spAAA患者18185例,均接受OAR或EVAR。

主要发现

  • fAAA患者较spAAA患者更年轻(P < .001),术前居家比例更高(P = .008)。
  • fAAA患者冠心病(P = .001)和高血压(P = .039)发生率更低,吸烟率和终末期肾病无差异。
  • fAAA患者髂动脉瘤样变(P < .001)和接受OAR(P < .001)的比例更高。
  • OAR后fAAA患者需同期肾动脉旁路手术更多(P = .012),但拔管更早(P = .005)、输血更少(P < .001)、住院更短(P = .018),复合早期并发症减少(P = .020)。
  • EVAR后fAAA患者早期腰支内漏(II型)更多,但近端IA型内漏(P = .279)、因瘤囊增大(P = .786)、任何内漏(P = .439)或破裂(P = .649)的晚期再干预率无差异;spAAA患者ICU停留更长(P < .001)且输血更多(P < .001),两组术后并发症(P = .510)、30天死亡率(P = .177)和长期死亡率(P = .259)相似。

临床怎么用

  • 原文未据此给出推荐,仅结论指出EVAR和OAR对fAAA患者均安全有效。

局限性

  • 原文指出需要更长期随访的进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent investigations have reported increased rates of aneurysm-related complications after endovascular aneurysm repair (EVAR) in familial abdominal aortic aneurysm (fAAA) patients. The purpose of this study was to evaluate the outcomes of open aortic repair (OAR) and EVAR in sporadic AAA (spAAA) and fAAA patients in the Society for Vascular Surgery Vascular Quality Initiative. METHODS: This was a retrospective review of all AAA repairs in the Vascular Quality Initiative from 2003 to 2017. Patients' data were summarized, and standard statistical analysis was performed. Patients with known genetic syndromes and centers with long-term follow-up of <50% of patients were excluded. RESULTS: From 2003 to 2017, there were 1997 fAAA patients compared with 18,185 spAAA patients undergoing OAR and EVAR during the same study period. Compared with their spAAA counterparts, fAAA patients were younger (P < .001), were more likely to be living at home before surgery (P = .008), and demonstrated a lower incidence of coronary artery disease (P = .001) and hypertension (P = .039). Rates of smoking and end-stage renal disease did not differ between groups. However, fAAA patients were more likely to have aneurysmal degeneration of their iliac arteries (P < .001) and to undergo OAR (P < .001). When analyzing patients undergoing OAR, we found that fAAA patients were more likely to require concomitant renal bypass surgery (P = .012) but were extubated sooner (P = .005), received fewer blood transfusions (P < .001), and had a shorter length of stay (P = .018). Although individual complication rates did not differ between fAAA and spAAA groups after OAR, a composite end point of all early postoperative complications was decreased in fAAA patients (P = .020). When comparing fAAA and spAAA patients who underwent EVAR, we found a greater incidence of early lumbar branch endoleaks (type II) in fAAA patients; however, the rate of proximal type IA endoleaks (P = .279) and the rate of late reintervention for sac growth (P = .786), any endoleak (P = .439), or rupture (P = .649) did not differ between the groups. Whereas spAAA patients undergoing EVAR required longer postoperative intensive care unit stays (P < .001) and had a greater incidence of blood transfusions (P < .001), fAAA and spAAA patients had similar rates of postoperative complications (P = .510), 30-day mortality (P = .177), and long-term mortality (P = .259). CONCLUSIONS: This study shows that patients with a familial form of AAA do not have increased morbidity or mortality after AAA repair. Our findings suggest that EVAR and OAR are both safe and effective for fAAA patients. Further studies with longer follow-up are needed to best care for this unique cohort of patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ryer EJ, Garvin RP, Zhou Y, et al. Outcomes of familial abdominal aortic aneurysm repair in the Vascular Quality Initiative. J Vasc Surg. 2018. PMID: 30064833. doi:10.1016/j.jvs.2018.04.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。